Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG)
Clinical trial NCT05733572 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05733572
- Sponsor
- Benedetto Falsini
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2026-06-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.